Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhuoya Deng

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Microbiology|October 21, 2022
mRNA vaccines: A novel weapon to control infectious diseasesYuying Tian, Zhuoya Deng, Penghui Yang
International Immunopharmacology|May 19, 2023
A recombinant oncolytic influenza virus expressing a PD-L1 antibody induces CD8<sup>+</sup> T-cell activation via the cGas-STING pathway in mice with hepatocellular carcinomaFang Sun, Yan Xu, Zhuoya Deng, et al.
Frontiers in Immunology|June 20, 2022
mRNA Vaccines: The Dawn of a New Era of Cancer ImmunotherapyZhuoya Deng, Yuying Tian, Jianxun Song, et al.
Frontiers in Immunology|March 12, 2025
HIV controllers: hope for a functional cureZhuoya Deng, Hongxia Yan, Olivier Lambotte, et al.
Frontiers in Oncology|October 31, 2022
An OX40L mRNA vaccine inhibits the growth of hepatocellular carcinomaZhuoya Deng, Hao Yang, Yuying Tian, et al.
Nanoscale Advances|December 26, 2024
Platinum nanoparticles wrapped in carbon-dot-films as oxygen reduction reaction catalysts prepared by solution plasma sputteringYuanyuan Liu, Zhunda Zhu, Pengfei Wang, et al.
RSC Advances|April 23, 2025
Synthesis of size-controlled PtPdIr nanoparticles by solution plasma sputtering and their catalytic propertiesYuanyuan Liu, Zhunda Zhu, Zhuoya Deng, et al.
Journal of Medical Virology|November 29, 2025
Subset Remodeling of MAIT and NK Cells Correlates With Immune Reconstitution in People Living With HIV Following Four Years of Antiretroviral TherapyZhuoya Deng, Xin Zhang, Aiwei Zhu, et al.
International Journal of Nanomedicine|March 24, 2025
Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAsZhuoya Deng, Yuying Tian, Jing Wang, et al.
Virology|May 28, 2024
A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challengeYuying Tian, Zhuoya Deng, Zhengran Chuai, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Microbiology|October 21, 2022
mRNA vaccines: A novel weapon to control infectious diseasesYuying Tian, Zhuoya Deng, Penghui Yang
International Immunopharmacology|May 19, 2023
A recombinant oncolytic influenza virus expressing a PD-L1 antibody induces CD8<sup>+</sup> T-cell activation via the cGas-STING pathway in mice with hepatocellular carcinomaFang Sun, Yan Xu, Zhuoya Deng, et al.
Frontiers in Immunology|June 20, 2022
mRNA Vaccines: The Dawn of a New Era of Cancer ImmunotherapyZhuoya Deng, Yuying Tian, Jianxun Song, et al.
Frontiers in Immunology|March 12, 2025
HIV controllers: hope for a functional cureZhuoya Deng, Hongxia Yan, Olivier Lambotte, et al.
Frontiers in Oncology|October 31, 2022
An OX40L mRNA vaccine inhibits the growth of hepatocellular carcinomaZhuoya Deng, Hao Yang, Yuying Tian, et al.
Nanoscale Advances|December 26, 2024
Platinum nanoparticles wrapped in carbon-dot-films as oxygen reduction reaction catalysts prepared by solution plasma sputteringYuanyuan Liu, Zhunda Zhu, Pengfei Wang, et al.
RSC Advances|April 23, 2025
Synthesis of size-controlled PtPdIr nanoparticles by solution plasma sputtering and their catalytic propertiesYuanyuan Liu, Zhunda Zhu, Zhuoya Deng, et al.
Journal of Medical Virology|November 29, 2025
Subset Remodeling of MAIT and NK Cells Correlates With Immune Reconstitution in People Living With HIV Following Four Years of Antiretroviral TherapyZhuoya Deng, Xin Zhang, Aiwei Zhu, et al.
International Journal of Nanomedicine|March 24, 2025
Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAsZhuoya Deng, Yuying Tian, Jing Wang, et al.
Virology|May 28, 2024
A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challengeYuying Tian, Zhuoya Deng, Zhengran Chuai, et al.
Pageof 2